This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Improved therapeutic consistency and efficacy of CD317+ MSCs through stabilizing TSG6 by PTX3
Stem Cell Research & Therapy Open Access 27 March 2024
-
CD317+ MSCs expanded with chemically defined media have enhanced immunological anti-inflammatory activities
Stem Cell Research & Therapy Open Access 02 January 2024
-
TNFAIP6 defines the MSC subpopulation with enhanced immune suppression activities
Stem Cell Research & Therapy Open Access 24 September 2022
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Shi, Y. et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat. Rev. Nephrol. 14, 493–507 (2018).
Xu, J. Immunue modulation by mesenchymal stem cells. Cell Prolif. 53, e12712 (2020).
Wuchter, P. et al. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications. Cytotherapy 17, 128–139 (2015).
Xu, J. et al. Additive therapeutic effects of mesenchymal stem cells and IL-37 for systemic lupus erythematosus. J. Am. Soc. Nephrol. 31, 54–65 (2020).
Reis, M. et al. Global phenotypic characterisation of human platelet lysate expanded MSCs by high-throughput flow cytometry. Sci. Rep. 8, 3907 (2018).
Kong, C. M., Lin, H. D., Biswas, A., Bongso, A. & Fong, C. Y. Manufacturing of human Wharton’s jelly stem cells for clinical use: selection of serum is important. Cytotherapy 21, 483–495 (2019).
Wang, Y. et al. Understanding the immunological mechanisms of mesenchymal stem cells in allogeneic transplantation: from the aspect of major histocompatibility complex class I. Stem Cells Dev. 28, 1141–1150 (2019).
Ankrum, J. A., Ong, J. F. & Karp, J. M. Mesenchymal stem cells: immune evasive, not immune privileged. Nat. Biotechnol. 32, 252–260 (2014).
Deuse, T. et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat. Biotechnol. 37, 252–258 (2019).
Acknowledgements
This work was supported by the Natural Science Foundation of Shenzhen (JCYJ20180305163407913 and KQJSCX20180328093434771), Guangdong Provincial Science and Technology Program (No. 2019B030301009) and the Medical Foundation of Guangdong (A2018308).
Author information
Authors and Affiliations
Contributions
J.X. designed and supervised the project, interpreted the data, and wrote the manuscript; W.L. conducted the cell culture experiments; H.W. and X.W. conducted the animal studies; J.C., L.Y. and X.Z. collected the clinical samples and conducted the animal studies; and L.L. and Z.H. analyzed the data and corrected the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics
This study was approved by the ethics committee of Shenzhen University and followed the tenets of the Declaration of Helsinki.
Informed consent
Informed consent was obtained from participants prior to study participation.
Supplementary information
Rights and permissions
About this article
Cite this article
Xu, J., Lian, W., Wu, H. et al. Improved therapeutic consistency and efficacy of mesenchymal stem cells expanded with chemically defined medium for systemic lupus erythematosus. Cell Mol Immunol 17, 1104–1106 (2020). https://doi.org/10.1038/s41423-020-0364-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-020-0364-4
This article is cited by
-
Improved therapeutic consistency and efficacy of CD317+ MSCs through stabilizing TSG6 by PTX3
Stem Cell Research & Therapy (2024)
-
CD317+ MSCs expanded with chemically defined media have enhanced immunological anti-inflammatory activities
Stem Cell Research & Therapy (2024)
-
TNFAIP6 defines the MSC subpopulation with enhanced immune suppression activities
Stem Cell Research & Therapy (2022)
-
Chemical-defined medium supporting the expansion of human mesenchymal stem cells
Stem Cell Research & Therapy (2020)